Cactus pear extracts induce reactive oxygen species production and apoptosis in ovarian cancer cells

Nutrition and Cancer

Volumn 62, Issue 5, 2010, Pages 692-699

  Feugang, Jean M ^a   Ye, Fei ^b   Zhang, David Y ^b   Yu, Yanhong ^c   Zhong, Mei ^c   Zhang, Sui ^d   Zou, Changping ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CACTUS PEAR EXTRACT; CASPASE 3; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; PLANT EXTRACT; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER PREVENTION; CELL CYCLE; CELL IMMORTALIZATION; CELL PROTECTION; CONTROLLED STUDY; DNA FRAGMENTATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CANCER; SIGNAL TRANSDUCTION; TREATMENT DURATION; UPREGULATION; ANTAGONISTS AND INHIBITORS; CACTACEAE; DRUG EFFECTS; FRUIT; GENE EXPRESSION REGULATION; METABOLISM; OVARIAN NEOPLASMS; PATHOLOGY;

CACTACEAE; PYRUS;

APOPTOSIS; CACTACEAE; FEMALE; FRUIT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NF-KAPPA B; OVARIAN NEOPLASMS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

EID: 77953994957     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605508     Document Type: Article

References (56)

1. American Cancer Society: Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 2004.
2. Badgwell D and Bast RJ: Early detection of ovarian cancer. Dis Markers 23, 397-410, 2007.
3. Berchuck A, Elbendary A, Havrilesky L, Rodriguez G, and Bast RJ: Pathogenesis of ovarian cancers. J Soc Gynecol Investig 1, 181-190, 1994.
4. Scully R: Pathology of ovarian cancer precursors. J Cell Biochem 23, S208-S218, 1995.
5. Bast RJ, Brewer M, Zou C, Hernandez M, Daley M, et al.: Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res 174, 91-100, 2007.
6. American Cancer Society: Cancer Statistics 2004. Atlanta, GA: American Cancer Society, 2004.
7. Kelloff G, Crowell J, Steel V, Lubet R, Boone C, et al.: Progress in cancer chemoprevention. Ann NY Acad Sci 889, 1-13, 1999.
8. Kelloff G, Crowell J, Steele V, Lubet R,Malone W, et al.: Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130, 467S-471S, 2000.
9. Kelloff G, Sigman C, and Greenwald P: Cancer chemoprevention: progress and promise. Eur J Cancer 35, 2031-2038, 1999.
10. Steele V, Sharma S, Mehta R, Elmore E, Redpath L, et al.: Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cell Biochem 26, 29-53, 1996.
11. Supino R, Crosti M, Clerici M, Warlters A, Cleris L, et al.: Induction of apoptosis by fenretinide (4-HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression. Intl J Cancer 65, 491-497, 1996.
12. Brewer M, Ranger-Moore J, Satterfield W, Hao Z,Wang J, et al.: Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer. Front Biosci 12, 2260-2268, 2007.
13. Veronesi U, De Palo G, Marubini E, CostaA, Formelli F, et al.: Randomized trial of fenretinide to prevent second breastmalignancy inwomen with early breast cancer. J Natl Cancer Inst 91, 1847-1856, 1999.
14. Johnson IT: Phytochemicals and cancer. Proc Nutr Soc 66, 207-215, 2007.
15. Steinmetz K and Potter J: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96, 1027-1039, 1996.
16. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP, et al.: Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120, 451-458, 2007.
17. Imai K, Suga K, and Nakachi K: Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med 26, 769-775, 1997.
18. Mukhtar H and Ahmad N: Green tea in chemoprevention of cancer. Toxicol Sci 52, 111-117, 1999.
19. Yang CS andWang ZY: Tea and cancer. J Natl Cancer Inst 85, 1038-1049, 1993.
20. ZouD, BrewerM,Garcia F, Feugang J,Wang J, et al.: Cactus pear: a natural product in cancer chemoprevention. Nutr J 4, 25, 2005.
21. Feugang J, Konarski P, Zou D, Stintzing F, and Zou C: Nutritional and medicinal use of cactus pear (Opuntia spp.) cladodes and fruits. Front Biosci 11, 2574-2589, 2006. (Pubitemid 43806566)
22. Halliwell B and Aruoma OI: DNA damage by oxygen-derived species Its mechanism and measurement in mammalian systems. FEBS Letters 281, 9-19, 1991.
23. Valko M, Rhodes CJ, Moncol J, Izakovic M, and Mazur M: Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico- Biological Interactions 160, 1-40, 2006.
24. Zhao W, Diz DI, and Robbins ME: Oxidative damage pathways in relation to normal tissue injury. Br J Radiol 80, S23-S31, 2007.
25. Halliwell B and Gutteridge J: Free Radicals in Biology and Medicine. Oxford, England: Oxford University Press, 1999.
26. Zou CP, Kurie JM, Lotan D, Zou CC, Hong WK, et al.: Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Clin Cancer Res 4, 1345-1355, 1998.
27. Cornett JW: How Indians Used Desert Plants. Palm Springs, CA: Nature Trails Press, 2000.
28. Kay M: Healing With Plants in the American and Mexican West. Tucson, AZ: University of Arizona Press, 1996.
29. Knishinsky R: Prickly Pear Cactus Medicine. Rochester, VT: Healing Arts Press, 1971.
30. Ozben T:Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96, 2181-2196, 2007.
31. Haddad JJ: Redox and oxidant-mediated regulation of apoptosis signaling pathways: immuno-pharmaco-redox conception of oxidative siege versus cell death commitment. Int Immunopharmacol 4, 475-493, 2004.
32. Nicotera TM, Privalle C, Wang TC, Oshimura M, and Barrett JC: Differential proliferative responses of Syrian hamster embryo fibroblasts to paraquat-generated superoxide radicals depending on tumor suppressor gene function. Cancer Res 54, 3884-3888, 1994.
33. Hileman E, Liu J, Albitar M, Keating M, and Huang P: Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity. Cancer Chemother Pharmacol 53, 209-219, 2004.
34. Hu Y, Rosen DG, Zhou Y, Feng L, Yang G, et al.: Mitochondrial manganese-superoxide dismutase expression in ovarian cancer: role in cell proliferation and response to oxidative stress. J Biol Chem 280, 39485-39492, 2005.
35. Huang C, Ke Q, Costa M, and Shi X: Molecular mechanisms of arsenic carcinogenesis. Mol Cell Biochem 255, 57-66, 2004.
36. Pelicano H, Carney D and Huang P: ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7, 97-110, 2004.
37. Toyokuni S, Okamoto K, Yodoi J, and Hiai H: Persistent oxidative stress in cancer. FEBS Letters 358, 1-3, 1995.
38. Zhou Y, Hileman EO, Plunkett W, Keating MJ, and Huang P: Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents. Blood 101, 4098-4104, 2003.
39. Narayanan BA: Chemopreventive agents alters global gene expression pattern: predicting their mode of action and targets. Curr Cancer Drug Targets 6, 711-727, 2006.
40. SerafiniM, Villano D, Spera G, and Pellegrini N: Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer 56, 232-240, 2006.
41. Simone Cn, Simone N, Simone V, and Simone C: Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival: part 2. Altern Ther Health Med 13, 40-47, 2007. (Pubitemid 46427632)
42. Simone Cn, Simone N, Simone V, and Simone C: Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival: part 1. Altern Ther Health Med 13, 22-28, 2007. (Pubitemid 46110631)
43. Chan MM, Soprano KJ, Weinstein K, and Fong D: Epigallocatechin-3- gallate delivers hydrogen peroxide to induce death of ovarian cancer cells and enhances their cisplatin susceptibility. J Cell Physiol 207, 389-396, 2006.
44. Yamamoto T, Lewis J, Wataha J, Dickinson D, Singh B, et al.: Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J Pharmacol Exp Ther 308, 317-323, 2004.
45. Genestra M: Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cellular Signal 19, 1807-1819, 2007.
46. Yin Y, Solomon G, Deng C, and Barrett JC: Differential regulation of p21 by p53 and Rb in cellular response to oxidative stress. Mol Carcinog 24, 1098-2744, 1999.
47. Menon SG and Goswami PC: A redox cycle within the cell cycle: ring in the old with the new. Oncogene 26, 1101-1109, 2006.
48. O'Reilly MA: Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death. Antioxid Redox Signal 7, 108-118, 2005.
49. AmiriKI and Richmond A: Role of nuclear factor-κ B inmelanoma. Cancer and Metastasis Rev 24, 301-313, 2005.
50. Angel P and Karin M: The role of Jun, Fos, and the AP-1 complex in cellproliferation and transformation. Biochim Biophys Acta (BBA)-Reviews on Cancer 1072, 129-157, 1991.
51. Lin A and Karin M: NF-[kappa]B in cancer: a marked target. Semin Cancer Biol 13, 107-114, 2003.
52. Van Waes C: Nuclear factor-{kappa}B in development, prevention, and therapy of cancer. Clin Cancer Res 13, 1076-1082, 2007.
53. Lee C, Jeon Y, Kim S, and Song Y: NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29, 19-35, 2007.
54. Sarkar F and Li Y: NF-kappaB: a potential target for cancer chemoprevention and therapy. Front Biosci 13, 2950-2959, 2008. (Pubitemid 351589211)
55. Garban HJ and Bonavida B: Nitric oxide disrupts H2O2-dependent activation of nuclear factor kappa B role in sensitization of human tumor cells to tumor necrosis factor-alpha-induced cytotoxicity. J Biol Chem276, 8918-8923, 2001.
56. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825, 1993.